Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cogane in early-stage Parkinson's Disease
NCT01060878Phase 2Completed
- Sponsor
- Phytopharm plc
- Start
- Nov 2010
- Primary completion
- Dec 2012
- Modality
- Classical Binding Small Molecules
- Countries
- 10
01
Overview
A Phase 2 trial of smilagenin in Parkinson's disease (PD), sponsored by Phytopharm plc. Started Nov 2010; status: completed.
02
Drugs
smilagenin
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01060878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01060878.